PL2504350T3 - Sposób oczyszczania glikoprotein - Google Patents

Sposób oczyszczania glikoprotein

Info

Publication number
PL2504350T3
PL2504350T3 PL10788242T PL10788242T PL2504350T3 PL 2504350 T3 PL2504350 T3 PL 2504350T3 PL 10788242 T PL10788242 T PL 10788242T PL 10788242 T PL10788242 T PL 10788242T PL 2504350 T3 PL2504350 T3 PL 2504350T3
Authority
PL
Poland
Prior art keywords
glycoproteins
purification
Prior art date
Application number
PL10788242T
Other languages
English (en)
Polish (pl)
Inventor
Steffen Goletz
Lars Stöckl
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42173838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2504350(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of PL2504350T3 publication Critical patent/PL2504350T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10788242T 2009-11-24 2010-11-24 Sposób oczyszczania glikoprotein PL2504350T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26393109P 2009-11-24 2009-11-24
EP09014585A EP2325194A1 (en) 2009-11-24 2009-11-24 Process for the purification of glycoproteins
EP10788242.5A EP2504350B1 (en) 2009-11-24 2010-11-24 Process for the purification of glycoproteins

Publications (1)

Publication Number Publication Date
PL2504350T3 true PL2504350T3 (pl) 2017-08-31

Family

ID=42173838

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10788242T PL2504350T3 (pl) 2009-11-24 2010-11-24 Sposób oczyszczania glikoprotein

Country Status (12)

Country Link
US (1) US8846344B2 (enExample)
EP (2) EP2325194A1 (enExample)
JP (1) JP5840135B2 (enExample)
KR (1) KR101860830B1 (enExample)
CN (1) CN102656182B (enExample)
AU (1) AU2010324104C1 (enExample)
CA (1) CA2781132A1 (enExample)
DK (1) DK2504350T3 (enExample)
ES (1) ES2626248T3 (enExample)
LT (1) LT2504350T (enExample)
PL (1) PL2504350T3 (enExample)
WO (1) WO2011063943A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470672B2 (en) 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
EP3131571A1 (en) 2014-04-18 2017-02-22 Glycotope GmbH Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
AR100131A1 (es) * 2014-04-18 2016-09-14 Cadila Healthcare Ltd Proceso de purificación de gonadotropina
EP3145950B1 (en) * 2014-05-23 2019-01-09 Instituto Massone S.A. A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
CN108348465B (zh) 2015-09-17 2020-11-10 葛莱高托普有限公司 具有提高的稳定性的哺乳动物促卵泡激素组合物
PH12018502104B1 (en) * 2016-03-31 2024-03-27 Spark Therapeutics Inc Column-based fully scalable raav manufacturing process
CN106008662A (zh) * 2016-05-16 2016-10-12 南京农业大学 一种以枸杞蜂花粉为原料制备富锌中性糖蛋白的方法
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN106732464B (zh) * 2017-02-02 2020-11-20 复旦大学 一种亲水树枝和c18修饰的磁性石墨烯材料及其制备方法和应用
US11385238B2 (en) * 2017-06-30 2022-07-12 Amgen Inc. Methods of protein clips recovery
CN110563832B (zh) * 2019-07-31 2025-11-14 江苏璟泽生物医药有限公司 一种高纯度重组促卵泡刺激素纯化方法
EP4073083A1 (en) * 2019-12-12 2022-10-19 EMD Millipore Corporation Intensified virus filtration using diafiltration buffer
EP3964523A1 (en) * 2020-09-04 2022-03-09 PreviPharma Consulting GmbH Preparation of fetuin a by hydrophobic interaction chromatography
CN114835796A (zh) * 2022-05-05 2022-08-02 江苏尤里卡生物科技有限公司 一种促性腺激素纯化方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
AU606099B2 (en) * 1986-12-07 1991-01-31 Japan Science And Technology Corporation Colony-stimulating factor and method for preparation thereof
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
HK1000547A1 (en) 1989-12-22 1998-04-03 Merck Serono Sa Endogenous gene expression modification with regulatory element by way of homologous recombination
DE69131978T2 (de) 1990-05-08 2000-10-05 University Of Medicine And Dentistry Of New Jersey, Newark Glykoproteinhormon-analoga mit veränderten immunologischen merkmalen, veränderter wirksamkeit und/oder rezeptorspezifität
DE69231129D1 (de) 1991-06-18 2000-07-06 Univ New Jersey Med Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben
IL117849A (en) 1995-04-14 2002-07-25 Lepetit Spa Chromatographic process for clearing glycoproteins
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
IT1287138B1 (it) 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
PT996629E (pt) 1997-06-25 2006-12-29 Applied Research Systems Análogos de hormonas glicoproteicas reticulados com ligações dissulfito, sua preparação e utilização
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
IL139432A0 (en) 1998-05-07 2001-11-25 Transkaryotic Therapies Inc Modifying the expression of the fsh beta gene by homologous recombination
PL346127A1 (en) 1998-07-23 2002-01-28 Lilly Co Eli Fsh and fsh variant formulations, products and methods
EP1169349B1 (en) 1999-04-16 2007-03-28 Instituto Massone S.A. Process for preparing gonadotropin compositions
WO2001058493A1 (en) 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
SE0001660D0 (sv) 2000-05-05 2000-05-05 Gramineer Ab Separation of glyco-containing entities
PT1610822E (pt) 2003-04-02 2011-01-05 Ares Trading Sa Formulações farmacêuticas líquidas ou liofilizadas de fsh e/ou lh em conjunto com o surfactante não iónico poloxâmero 188 e um agente bacteriostático
ES2333128T3 (es) 2003-12-22 2010-02-17 Ares Trading S.A. Metodo para purificar fsh.
NZ548513A (en) * 2004-01-14 2010-05-28 Univ Ohio Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
WO2005110015A2 (en) * 2004-04-19 2005-11-24 Ohio University Cross-linkable glycoproteins and methods of making the same
SI1809663T1 (sl) * 2004-11-09 2009-02-28 Ares Trading Sa Postopek za äśiĺ äśenje fsh
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
JP5364382B2 (ja) 2006-02-07 2013-12-11 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 遊離チオール部分を有するタンパク質の安定化された組成物
PT2170942E (pt) 2007-06-28 2013-10-22 Biogenerix Ag Clone celular produtor de fsh
DE102008002209A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin

Also Published As

Publication number Publication date
CN102656182A (zh) 2012-09-05
KR101860830B1 (ko) 2018-05-24
JP2013511481A (ja) 2013-04-04
AU2010324104B2 (en) 2015-02-19
ES2626248T3 (es) 2017-07-24
DK2504350T3 (en) 2017-06-12
CA2781132A1 (en) 2011-06-03
AU2010324104C1 (en) 2015-06-11
CN102656182B (zh) 2015-03-18
EP2504350A1 (en) 2012-10-03
US8846344B2 (en) 2014-09-30
JP5840135B2 (ja) 2016-01-06
EP2504350B1 (en) 2017-05-10
EP2325194A1 (en) 2011-05-25
LT2504350T (lt) 2017-06-12
US20120252069A1 (en) 2012-10-04
KR20120089755A (ko) 2012-08-13
AU2010324104A1 (en) 2012-06-07
WO2011063943A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
PL2504350T3 (pl) Sposób oczyszczania glikoprotein
ZA201202504B (en) Process for the preparation of calcobutrol
PL2425721T3 (pl) Sposób oczyszczania wysokiej czystości mogrozydów
IL261526A (en) Methods for the purification of deoxycholic acid
PT2913337T (pt) Processo para a produção de sofosbuvir
ZA201200409B (en) Compounds for the reduction of b-amyloid production
ZA201202523B (en) Method for the purification of adenovirus particles
GB0922623D0 (en) Methods for the purification of cucurbituril
IL214374A0 (en) Process for purifying lipopeptides
IL243248A0 (en) Purification method
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
IL216942A0 (en) Process for the manufacture of alkenones
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
ZA201105709B (en) Process for the synthesis of cleistanthin
ZA201300320B (en) Purification process
EP2516412A4 (en) PROCESS FOR CLEANING LUBIPROSTON
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
SI2391633T1 (sl) Postopek za pridobivanje beta-acetilfuranozida
HUE11718776T2 (hu) Ipari eljárás (S)-(+)-pregabalin elõállítására
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
ZA201201657B (en) Processes for the preparation of vardenafil
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
IL220160A (en) A process for the preparation of defrasirox
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
PL388929A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych alkoksysilanów